Nerano Pharma’s Strategic Funding Partnership With Advanced Oncotherapy plc

Macfarlanes has advised Nerano Pharma Limited on the provision of an interest-bearing secured convertible facility to Advanced Oncotherapy plc. Advanced Oncotherapy will use the funding to…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Paolo Bossi

This content is for Standard 1 Year members only.
Login Join Now